CincyTech CEO Mike Venerable was talking to Venture Investor and former NFL linebacker Dhani Jones about the lack of diversity in venture capital. Jones was blunt with his answer, “You need to invest with more black investors.”Venerable rememb

Uncertain about college or career now? Peerro has an app that can help.

Oct 7th, 2021 34m 9s

Once upon a time, people learned trades or skills from a skilled employer until they mastered the work for themselves. The practice was called an apprenticeship. And it especially common in skilled trades. Fast forward to today and there remain

A look into your heart in 90 seconds with Peeyush Shrivastava

Sep 22nd, 2021 24m 19s

More than 8 million people go to the emergency room for chest pains every year. But 3 out 4 of the cases do not involve heart-related issues. Founded in 2017, Genetesis markets the CardioFlux® medical imaging device to hospital emergency rooms

What will the future of work look like? Chris Powell thinks he knows.

Aug 31st, 2021 23m 16s

The pandemic may have forever changed the way we view work. This is especially true for those who work remotely. Remote workers have become accustomed to a new normal of sorts where they can accomplish multiple tasks while still putting in the

Abre.io: Connecting the Village of Education

Aug 31st, 2021 34m 44s

Abre was launched by two educators in a small school district when they could not find software solutions to help link burgeoning EdTech growth in classrooms. So, they created a simpler, one-stop shop for their learning community. Today, Abre i

How to better identify potential mental health risks

Aug 19th, 2021 42m 44s

CincyTech Chief Executive Officer Mike Venerable talks with Clarigent Health Founder and Chief Executive Officer Don Wright about the escalation of mental health challenges during the pandemic. They also discuss Clarigent's involvement with a j

How to make a cancer cell obey

Aug 11th, 2021 34m 49s

On this episode of "Let's Not Talk About Covid," CincyTech CEO Mike Venerable talks to Jan Rosenbaum, CEO and Chief Science Officer of Kurome Therapeutics, about the company's research and recent Series A funding round, Rosenbaum is a former sc

Rate